Bayer CropScience Board to Consider Unaudited Financial Results on February 11, 2026

Bayer CropScience has announced that a meeting of its Board of Directors will be held on Wednesday, February 11, 2026, to consider and approve the unaudited financial results for the quarter ended December 31, 2025. The company has also declared the closure of the trading window for designated persons in accordance with insider trading regulations.

Board Meeting Announcement

Bayer CropScience is set to convene a meeting of its Board of Directors to review the company’s financial performance. The meeting is scheduled for February 11, 2026.

Agenda: Unaudited Financial Results

The primary agenda of the board meeting is to discuss and approve the unaudited financial results for the quarter ending December 31, 2025 (Q3).

Trading Window Closure

In compliance with regulations, the trading window for designated individuals has been closed. This measure aims to prevent insider trading activities and ensure fair market practices for all stakeholders.

Source: BSE

Previous Article

CG Power Board Approves Interim Dividend and Re-appoints Sriram Sivaram

Next Article

Ashok Leyland Jasmeet Bhatia Appointed President & Head of Human Resources